Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Antimycin A4: Protocols for Dual ATP-Citrate Lyase Inhibitio
2026-05-29
Antimycin A4 stands out as a precision ATP-citrate lyase inhibitor and mitochondrial respiratory chain blocker, enabling advanced dissection of cellular energy metabolism. This guide provides actionable workflows, troubleshooting strategies, and experimental insights to maximize research reproducibility and interpretability when using this dual-action compound.
-
Methotrexate as a Folate Antagonist: Translational Power & F
2026-05-29
This thought-leadership article explores the mechanistic underpinnings and strategic opportunities of methotrexate as a folate antagonist, focusing on its unique dual roles in apoptosis research and immunosuppression. Bridging robust experimental protocols with translational insight, it guides researchers through emerging applications, evidence-driven workflows, and the evolving landscape of anti-inflammatory and neurological research.
-
Adefovir (GS-0393): Optimizing HBV Antiviral Workflows
2026-05-28
Adefovir (GS-0393) empowers hepatitis B virus research with robust, selective inhibition of HBV DNA polymerase. This article delivers actionable protocols, advanced troubleshooting, and comparative insights that help researchers achieve reproducible, high-fidelity results in both antiviral and renal transporter assay contexts.
-
Tacrine Hydrochloride Hydrate: Scaffold Innovation in Alzhei
2026-05-28
Explore how Tacrine hydrochloride hydrate serves as a versatile molecular scaffold driving multi-target drug discovery in Alzheimer's disease research. This in-depth article reveals mechanistic insights, advanced applications, and practical assay guidance beyond traditional cholinesterase inhibition.
-
Cy3 NHS ester (non-sulfonated): Technical Guide for Protein
2026-05-27
Cy3 NHS ester (non-sulfonated) is a specialized fluorescent dye designed for covalent labeling of primary amines on proteins, peptides, and oligonucleotides. It solves solubility and detection challenges in workflows requiring orange fluorescence and compatibility with standard TRITC filter sets, but is not suitable for applications involving water-only labeling buffers or long-term dye storage in solution.
-
Parathyroid hormone (1-34) (human) in Advanced Bone and Kidn
2026-05-27
Parathyroid hormone (1-34) (human) empowers researchers to model calcium homeostasis and bone metabolism with unrivaled quantitative control, bridging bench workflows from osteoporosis to next-generation kidney assembloids. Leveraging its high bioactivity and solubility, APExBIO’s reagent is the trusted backbone for reproducible, high-fidelity experimental systems.
-
Risedronate Sodium in Precision Delivery: Mechanisms and Pro
2026-05-26
Explore the advanced mechanisms of Risedronate Sodium as an FPP synthase inhibitor and its impact on bone metabolism research. This article uniquely examines inhaled nanoformulations and practical assay guidance, setting it apart in osteoporosis and emphysema research.
-
Redefining Redox Control: TCEP Hydrochloride in Translationa
2026-05-26
This article explores the mechanistic and strategic impact of Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) as a next-generation reducing agent. By integrating recent mechanistic insights (notably from DNA-protein crosslink repair) with workflow innovation and translational relevance, it delivers actionable guidance for researchers optimizing redox-sensitive assays and protein analysis pipelines. Drawing from high-impact studies and benchmarking evidence, we position TCEP hydrochloride—supplied by APExBIO—as an indispensable tool for modern protein science.
-
Foxp1 Suppresses EndMT and Valvular Calcification in CKD Mod
2026-05-25
This study demonstrates that endothelial Foxp1 overexpression inhibits Notch pathway activation, suppressing endothelial-to-mesenchymal transition (EndMT) and attenuating valvular calcification in chronic kidney disease models. The findings highlight Foxp1 as a regulatory node in calcific valvular pathology, offering new mechanistic insight into PTH-mediated vascular remodeling.
-
Bifendate (DDB): Applied Protocols for Hepatoprotection & Au
2026-05-25
Bifendate (DDB) stands out as a robust hepatoprotective agent and autophagy inhibitor for both in vitro and in vivo studies, with precise workflow guidance and troubleshooting strategies. Discover how APExBIO’s DDB empowers reproducible research in hepatic lipid metabolism and injury models.
-
Rack1-Mediated Ferroptosis in Rat Hindgut Development and AR
2026-05-24
This study uncovers the role of Rack1 in regulating ferroptosis during hindgut development in a rat model of anorectal malformation (ARM), using spatial transcriptomics. The findings highlight a mechanistic link between Rack1 suppression, P38-MAPK pathway activation, and ferroptotic cell death, providing new insights for congenital disease and ferroptosis research.
-
Cy5 NHS ester(Et): Technical Guide for Reliable Amine Labeli
2026-05-23
Cy5 NHS ester(Et) provides researchers with a water-soluble, amine-reactive fluorescent labeling reagent for high-purity protein and biomolecule tagging in immunofluorescence, flow cytometry, and microscopy workflows. It is not compatible with ethanol-based protocols or long-term storage of working solutions, requiring careful handling for reproducible results.
-
Recent Advances in Ibuprofen Synthesis for Inflammation Rese
2026-05-22
This review analyzes cutting-edge synthetic methods for ibuprofen and naproxen, with a focus on practical, selective, and scalable approaches. The findings directly inform the design of more efficient COX inhibitors for advanced inflammation and pain pathway research.
-
A-1331852: Advanced BCL-XL Inhibitor Applications in Cancer
2026-05-22
A-1331852, a potent and selective BCL-XL inhibitor, enables precise induction of apoptosis in BCL-XL–dependent cancer and senescent cells. This article details optimized experimental workflows, comparative advantages, and troubleshooting strategies for maximizing research outcomes, with practical guidance drawn from recent mechanistic breakthroughs.
-
Polyethylenimine Linear (PEI, MW 40,000): Mechanistic Insigh
2026-05-21
Discover the advanced science behind Polyethylenimine Linear (PEI, MW 40,000) as a DNA transfection reagent for in vitro studies. This article reveals new mechanistic insights, protocol optimizations, and practical guidance for maximizing efficiency in transient gene expression and recombinant protein production.